Si Jun Zi decoction inhibits the growth of lung cancer by reducing the expression of PD-L1 through TLR4/MyD88/NF-κB pathway.
暂无分享,去创建一个
Jinhua Liu | Zichao Chen | Zhen Zhang | Wenjie Zhao | Yaqun Li | P. Sun | Dongmei Qi | Zhai-Dong Liu | Zhenyong Zhang
[1] Suhong Chen,et al. Chemical Constitution, Pharmacological Effects and the Underlying Mechanism of Atractylenolides: A Review , 2023, Molecules.
[2] H. Kan,et al. Lung cancer as adverse health effect by indoor radon exposure in China from 2000 to 2020: A systematic review and meta-analysis. , 2022, Indoor air.
[3] Dekai Zhang,et al. Understanding the role of Toll-like receptors in lung cancer immunity and immunotherapy , 2022, Frontiers in Immunology.
[4] Caicun Zhou,et al. Non‐small cell lung cancer in China , 2022, Cancer communications.
[5] X. Qiao,et al. Chemical analysis of the Chinese herbal medicine licorice (Gan-Cao): An update review. , 2022, Journal of ethnopharmacology.
[6] Hongbing Shen,et al. Analyses of rare predisposing variants of lung cancer in 6,004 whole genomes in Chinese. , 2022, Cancer cell.
[7] K. Kang,et al. Anticolon Cancer Effect of Korean Red Ginseng via Autophagy- and Apoptosis-Mediated Cell Death , 2022, Nutrients.
[8] L. Paz-Ares,et al. Emerging immune checkpoint inhibitors for the treatment of non-small cell lung cancer , 2022, Expert opinion on emerging drugs.
[9] Jinhua Xu,et al. Circular RNA hsa_circ_0068252 Functions in Cisplatin Resistance and Immune Response via miR-1304-5p/PD-L1 Axis in Non-Small Cell Lung Cancer , 2022, Chemotherapy.
[10] Jing Liu,et al. Elucidating the anti-aging mechanism of Si Jun Zi Tang by integrating network pharmacology and experimental validation in vivo , 2022, Aging.
[11] L. Meng,et al. The efficacy and safety of immune checkpoint inhibitor plus chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysis , 2022, Investigational New Drugs.
[12] Hongyu Zhang,et al. Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer , 2022, Cancer Immunology, Immunotherapy.
[13] Chang-Young Jang,et al. Ginsenoside Rg1 suppresses cancer cell proliferation through perturbing mitotic progression , 2021, Journal of ginseng research.
[14] S. Kim,et al. Phytochemistry of ginsenosides: Recent advancements and emerging roles , 2021, Critical reviews in food science and nutrition.
[15] B. Baradaran,et al. PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[16] Min Song,et al. Danggui Buxue Decoction enhances the anticancer activity of gemcitabine and alleviates gemcitabine-induced Myelosuppression. , 2021, Journal of ethnopharmacology.
[17] Ming Kong,et al. Efficacy of ginseng and its ingredients as adjuvants to chemotherapy in non-small cell lung cancer. , 2021, Food & function.
[18] X. Ren,et al. Morphine-3-glucuronide upregulates PD-L1 expression via TLR4 and promotes the immune escape of non-small cell lung cancer , 2021, Cancer biology & medicine.
[19] Wei Zhang,et al. Protective effects of Poria cocos and its components against cisplatin-induced intestinal injury. , 2020, Journal of ethnopharmacology.
[20] Feng Zhu,et al. FGD5-AS1 promotes cisplatin resistance of human lung adenocarcinoma cell via the miR-142-5p/PD-L1 axis , 2020, International journal of molecular medicine.
[21] A. Sica,et al. Regulation of PD-L1 Expression by NF-κB in Cancer , 2020, Frontiers in Immunology.
[22] A. Pourbagheri-Sigaroodi,et al. The role of toll‐like receptor 4 (TLR4) in cancer progression: A possible therapeutic target? , 2020, Journal of cellular physiology.
[23] Jingjing Li,et al. Synergistic breast cancer suppression efficacy of doxorubicin by combination with glycyrrhetinic acid as an angiogenesis inhibitor. , 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[24] J. Miao,et al. Recent Advances in the Tissue Culture of American Ginseng (Panax quinquefolius) , 2020, Chemistry & biodiversity.
[25] Li Yang,et al. Advances on hormone-like activity of Panax ginseng and ginsenosides. , 2020, Chinese journal of natural medicines.
[26] Hongyu Liu,et al. Advances in immune neoadjuvant/adjuvant therapy‐related adverse events of non‐small cell lung cancer , 2020, Asia-Pacific journal of clinical oncology.
[27] J. Bauml,et al. First-Line Therapy for Metastatic Non–Small Cell Lung Cancer: State-of-the-Art Targeted Therapy and Immunotherapy Approaches , 2020, Journal of the advanced practitioner in oncology.
[28] N. Aguilera,et al. T-cell lymphoproliferative processes in the spleen. , 2019, Seminars in diagnostic pathology.
[29] Daidi Fan,et al. Ginsenoside Rk1 induces apoptosis and downregulates the expression of PD-L1 by targeting the NF-κB pathway in lung adenocarcinoma. , 2019, Food & function.
[30] B. Majumder,et al. Ferulic acid enhances the radiation sensitivity of lung and liver carcinoma cells by collapsing redox homeostasis: mechanistic involvement of Akt/p38 MAPK signalling pathway , 2019, Free radical research.
[31] I. Song,et al. Interactions of ginseng with therapeutic drugs , 2019, Archives of Pharmacal Research.
[32] Liangzhi Li,et al. The antitumor effect of hinesol, extract from Atractylodes lancea (Thunb.) DC. by proliferation, inhibition, and apoptosis induction via MEK/ERK and NF‐κB pathway in non–small cell lung cancer cell lines A549 and NCI‐H1299 , 2019, Journal of cellular biochemistry.
[33] L. Qin,et al. The traditional uses, phytochemistry, and pharmacology of Atractylodes macrocephala Koidz.: A review. , 2018, Journal of ethnopharmacology.
[34] T. Schumacher,et al. Regulation and Function of the PD-L1 Checkpoint. , 2018, Immunity.
[35] Dawei Yuan,et al. Glycyrrhizin Suppresses the Growth of Human NSCLC Cell Line HCC827 by Downregulating HMGB1 Level , 2018, BioMed research international.
[36] Q-F Yue,et al. Liquiritin (LT) exhibits suppressive effects against the growth of human cervical cancer cells through activating Caspase-3 in vitro and xenograft mice in vivo. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[37] Toshiaki Suzuki,et al. Effect of ninjin’yoeito and ginseng extracts on oxaliplatin-induced neuropathies in mice , 2017, Journal of Natural Medicines.
[38] G. Hortobagyi,et al. Deubiquitination and Stabilization of PD-L1 by CSN5. , 2016, Cancer cell.
[39] Jingsheng Du,et al. Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway , 2016, Drug design, development and therapy.
[40] Jin-jian Lu,et al. A Systematic Review of the Anticancer Properties of Compounds Isolated from Licorice (Gancao) , 2015, Planta Medica.
[41] Jing-Gung Chung,et al. Glycyrrhizic Acid Modulates Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits Protein Kinase B- and Extracellular Signal-Regulated Kinase-Mediated Metastatic Potential in Hepatocellular Carcinoma In Vitro and In Vivo. , 2020, The American journal of Chinese medicine.
[42] Yanling Zhou,et al. Combination of liquiritin, isoliquiritin and isoliquirigenin induce apoptotic cell death through upregulating p53 and p21 in the A549 non-small cell lung cancer cells. , 2014, Oncology reports.